Ultrasound-guided radiofrequency ablation (RFA) has recently been used for the treatment of thyroid carcinomas. In this study, we aimed to evaluate the efficacy and safety of RFA for treating low-risk papillary thyroid carcinomas (PTCs). We searched the MEDLINE and the SCOPUS databases up to December 29, 2020, for studies assessing the efficacy and safety of RFA in the management of low-risk PTCs. Data on volume reduction ratio (VRR), complete disappearance, carcinoma recurrence, and complication frequency were collected. Thirteen studies with a total of 1389 patients and 1422 tumors were included in the synthesis of this study. Mean VRR varied between 47.8 and 100%, with most studies reporting a ratio of 98.5–100%. The ratio of complete disappearance ranged between 33.7 and 100%, although studies with a prolonged follow-up period reported a frequency of 56–100%. The tumor progression/recurrence frequency was 0–4.5%. Complications occurred in 45 patients (3.2%). Mild-moderate pain and cervical discomfort were the most common complications and no life-threatening complications were reported. Based on these data, we suggest that ultrasound-guided RFA can serve as an efficacious and safe alternative for the treatment of low-risk PTC in patients who are unable or unwilling to receive surgical therapy.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Wiltshire JJ, Drake TM, Uttley L, Balasubramanian SP (2016) Systematic review of trends in the incidence rates of thyroid cancer. Thyroid 26(11):1541–1552
La Vecchia C, Malvezzi M, Bosetti C et al (2015) Thyroid cancer mortality and incidence: a global overview. Int J Cancer 136(9):2187–2195
Ahn HS, Kim HJ, Welch HG (2014) Korea’s thyroid-cancer “epidemic” – screening and overdiagnosis. N Engl J Med 371:1765–1767
Lohia S, Hanson M, Tuttle RM, Morris LGT (2020) Active surveillance for patients with very low-risk thyroid cancer. Laryngoscope Investig Otolaryngol 5(1):175–182
Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133
Ze Y, Zhang X, Shao F et al (2019) Active surveillance of low-risk papillary thyroid carcinoma: a promising strategy requiring additional evidence. J Cancer Res Clin Oncol 145(11):2751–2759
Jung SL, Baek JH, Lee JH et al (2018) Efficacy and safety of radiofrequency ablation for benign thyroid nodules: a prospective multicenter study. Korean J Radiol 19(1):167–174
Cesareo R, Pasqualini V, Simeoni C, Sacchi M, Saralli E, Campagna G et al (2015) Prospective study of effectiveness of ultrasound-guided radiofrequency ablation versus control group in patients affected by benign thyroid nodules. J Clin Endocrinol Metab 100:460–466
Ugurlu MU, Uprak K, Akpinar IN, Attaallah W, Yegen C, Gulluoglu BM (2015) Radiofrequency ablation of benign symptomatic thyroid nodules: prospective safety and efficacy study. World J Surg 39:961–968
Chung SR, Baek JH, Choi YJ, Lee JH (2019) Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer. Eur Radiol 29(9):4897–4903
Lim HK, Baek JH, Lee JH, Kim WB, Kim TY, Shong YK et al (2015) Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer. Eur Radiol 25:163–170
Kim JH, Yoo WS, Park YJ, Park DJ, Yun TJ, Choi SH et al (2015) Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology 276:909–918
Mauri G, Gennaro N, Lee MK, Baek JH (2019) Laser and radiofrequency ablations for benign and malignant thyroid tumors. Int J Hyperthermia 36(2):13–20
De Bernardi IC, Floridi C, Muollo A, Giacchero R, Dionigi GL, Reginelli A, Gatta G, Cantisani V, Grassi R, Brunese L, Carrafiello G (2014) Vascular and interventional radiology radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: literature review. Radiol Med 119(7):512–520
Park HS, Baek JH, Park AW, Chung SR, Choi YJ, Lee JH (2017) Thyroid radiofrequency ablation: updates on innovative devices and techniques. Korean J Radiol 18(4):615–623
NHLBI Study Quality Assessment Tools. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed 30 June 2020
Wells GSB, O’Connell D, Peterson J, Welch V (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Eur J Epidemiol 25(9):603–605
Xiao J, Zhang Y, Zhang M, Lan Y, Yan L, Luo Y, Tang J (2020) Ultrasonography-guided radiofrequency ablation vs. surgery for the treatment of solitary T1bN0M0 papillary thyroid carcinoma: a comparative study. Clin Endocrinol (Oxf). https://doi.org/10.1111/cen.14361
Yan L, Luo Y, Zhang Y, Zhu Y, Xiao J, Lan Y, Tian X, Song Q, Xie F (2020) The clinical application of core-needle biopsy after radiofrequency ablation for low-risk papillary thyroid microcarcinoma: a large cohort of 202 patients study. J Cancer 11(18):5257–5263
Yan L, Lan Y, Xiao J, Lin L, Jiang B, Luo Y (2020) Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients. Eur Radiol. https://link.springer.com/article/10.1007%2Fs00330-020-07128-6
Cao XJ, Liu J, Zhu YL, Qi L, Liu G, Wang HL, Wang ZH, Zhou Y, He JF, Guo JQ, Shi LL, Jian M, Shataer A, Yan GZ, Zhao ZL, Wei Y, Peng LL, Li Y, Che Y, Wang SR, Yu MA (2020) Efficacy and safety of thermal ablation for solitary T1bN0M0 papillary thyroid carcinoma: a multicenter study. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa776
Cho SJ, Baek SM, Lim HK, Lee KD, Son JM, Baek JH (2020) Long-term follow-up results of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors. Thyroid. https://doi.org/10.1089/thy.2020.0106
Zhang M, Tufano RP, Russell JO et al (2020) Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years' follow-up. Thyroid 30(3):408–417
Xiao J, Zhang M, Zhang Y et al (2020) Efficacy and safety of ultrasonography-guided radiofrequency ablation for the treatment of T1bN0M0 papillary thyroid carcinoma: a retrospective study. Int J Hyperthermia 37(1):392–398
Wu R, Luo Y, Tang J et al (2020) Ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a retrospective analysis of 198 patients. Int J Hyperthermia 37(1):168–174
Zhang Y, Zhang MB, Luo YK, Li J, Zhang Y, Tang J (2019) Effect of chronic lymphocytic thyroiditis on the efficacy and safety of ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma. Cancer Med 8(12):5450–5458
Ding M, Tang X, Cui D et al (2019) Clinical outcomes of ultrasound-guided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma. Clin Radiol 74(9):712–717
Jeong SY, Baek JH, Choi YJ et al (2018) Radiofrequency ablation of primary thyroid carcinoma: efficacy according to the types of thyroid carcinoma. Int J Hyperthermia 34(5):611–616
Kim JH, Baek JH, Sung JY et al (2017) Radiofrequency ablation of low-risk small papillary thyroid carcinoma: preliminary results for patients ineligible for surgery. Int J Hyperthermia 33(2):212–219
Zhang M, Luo Y, Zhang Y, Tang J (2016) Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid 26(11):1581–1587
Yue W, Wang S, Yu S, Wang B (2014) Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience. Int J Hyperthermia 30(2):150–157
Teng D, Sui G, Liu C, Wang Y, Xia Y, Wang H (2018) Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study. J Cancer Res Clin Oncol 144(4):771–779
Teng DK, Li HQ, Sui GQ et al (2019) Preliminary report of microwave ablation for the primary papillary thyroid microcarcinoma: a large-cohort of 185 patients feasibility study. Endocrine 64(1):109–117
Zhou W, Jiang S, Zhan W, Zhou J, Xu S, Zhang L (2017) Ultrasound-guided percutaneous laser ablation of unifocal T1N0M0 papillary thyroid microcarcinoma: Preliminary results. Eur Radiol 27(7):2934–2940
Ji L, Wu Q, Gu J et al (2019) Ultrasound-guided percutaneous laser ablation for papillary thyroid microcarcinoma: a retrospective analysis of 37 patients. Cancer Imaging 19(1):16
Shen K, Xue S, Xie Y, Wang H, Li J, Sun Y, Wang K, Xu G, Guo T, Fan B, Zhu L, Ren A (2020) Comparison of thermal ablation and routine surgery for the treatment of papillary thyroid microcarcinoma: a systematic review and Meta-analysis. Int J Hyperthermia 37(1):913–924
Ma B, Wei W, Xu W et al (2018) Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation: a retrospective case review and literature review. Thyroid 28(9):1134–1142
Sun W, Zhang H, He L, Zhang T, Wang Z, Dong W, Jiang Y (2020) Surgery after ultrasound-guided radiofrequency ablation for papillary thyroid carcinoma in 21 patients: a retrospective study from a single center in China. Med Sci Monit 26:e928391
Tong M, Li S, Li Y, Li Y, Feng Y, Che Y (2019) Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis. Int J Hyperthermia 36(1):1278–1286
Kim JH, Baek JH, Lim HK, Ahn HS, Baek SM, Choi YJ, Choi YJ, Chung SR, Ha EJ, Hahn SY, Jung SL, Kim DS, Kim SJ, Kim YK, Lee CY, Lee JH, Lee KH, Lee YH, Park JS, Park H, Shin JH, Suh CH, Sung JY, Sim JS, Youn I, Choi M, Na DG, Guideline Committee for the Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology (2018) 2017 thyroid radiofrequency ablation guideline: Korean Society of Thyroid Radiology. Korean J Radiol 19:632–655
Che Y, Jin S, Shi C et al (2015) Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. AJNR Am J Neuroradiol 36(7):1321–1325
Yue WW, Wang SR, Li XL et al (2016) Quality of life and cost-effectiveness of radiofrequency ablation versus open surgery for benign thyroid nodules: a retrospective cohort study. Sci Rep 6:37838
Bernardi S, Dobrinja C, Carere A et al (2018) Patient satisfaction after thyroid RFA versus surgery for benign thyroid nodules: a telephone survey. Int J Hyperthermia 35(1):150–158
Conflict of interest
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Ntelis, S., Linos, D. Efficacy and safety of radiofrequency ablation in the treatment of low-risk papillary thyroid carcinoma: a review. Hormones (2021). https://doi.org/10.1007/s42000-021-00283-5
- Papillary carcinoma
- Radiofrequency ablation